Hemostasis Diagnostics Market: By Product Type (Systems, Consumables, Point-of-Care Testing Devices), By Test Type (Fibrinogen Test, Activated Clotting Time, Platelet Function, Prothrombin Time, Heparin & Protamine Dose-Response Test For ACT, Activated Partial Thromboplastin Time, Anti-Factor Xa, Other Coagulation Tests), By Technology (Optical, Mechanical, Electrochemical, Others), By End-User (Hospitals, Clinics, Diagnostic Centres, Others (POC)), and Geography

Purchase Option

$ 4400
$ 6600
$ 8900

Hemostasis Diagnostics Market size was valued at USD 3.98 billion in 2023 and is poised to grow at a CAGR of 9.1% from 2024-2030. Hemostasis diagnostics are the devices used to determine the hemostatic defects, which cause excessive bleeding. Hemostasis is defined as stopping or slowing the blood flow from the damaged blood vessel. During the hemostasis, blood changes from a liquid state to a gelatinous state. Hemostasis is maintained in the body by three mechanisms namely, blood coagulation, platelet plug formation, and vasoconstriction.

Hemostasis diagnostics may help to predict the cause of bleeding during surgery by identifying the hemostatic defects in patients. Different types of tests such as prothrombin test, activated clotting time, platelet function, and other coagulation tests are carried out to identify the hemostasis defects. The market is growing at a significant rate due to the rise in the prevalence of trauma conditions and various surgeries around the globe. Moreover, the rise in the prevalence of cardiovascular diseases, cancer, and diabetes is also expected to propel the market. Furthermore, acquisitions and mergers, collaborations, test approvals, and launchings are the strategies followed by the companies to increase their revenue share. For instance, in January 2017, Instrumentation Laboratory, a subsidiary of Werfen acquired Accriva Diagnostics for the expansion of its hemostasis testing portfolio. In addition, in June 2017, Grifols and Beckman Coulter entered into a distribution agreement for the distribution of Grifol hemostasis instruments, consumables, and reagents around the globe.  

Hemostasis Diagnostics Market Key Developments:

In November 2016, Siemens Healthineers launched the CE-marked Atellica COAG 360 system, a high-volume specialty analyzer used in the hemostasis diagnostics

Hemostasis Diagnostics Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

9.1%

Largest Market

North America

Fastest Growing Market

Asia Pacific
Hemostasis Diagnostics Market Dynamics

Increase in the incidence of blood clotting disorders such as haemophilia (according to National Hemophilia Foundation, approximately 400,000 incidences of haemophilia is observed in 2012), growing number of trauma patients and surgeries, and the introduction of biodegradable and cost-effective products are expected to propel the market growth over the forecast period. Moreover, technological advancements in the hemostasis diagnostics such as accurate results in less time, increase in awareness about the hemostasis diagnostics, and rise in R&D investment for novel tests and devices boost the market. However, the high cost of advanced hemostasis products and stringent regulations for the test approvals are expected to hamper the growth of market over the forecast period.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Hemostasis Diagnostics Market Segmentation

By Product Type
  • Systems,
  • Consumables,
  • Point-of-Care Testing Devices
By Test Type
  • Fibrinogen Test,
  • Activated Clotting Time,
  • Platelet Function,
  • Prothrombin Time,
  • Heparin & Protamine Dose-Response Test For ACT,
  • Activated Partial Thromboplastin Time,
  • Anti-Factor Xa,
  • Other Coagulation Tests
By Technology
  • Optical,
  • Mechanical,
  • Electrochemical,
  • Others
By End User
  • Hospitals,
  • Clinics,
  • Diagnostic Centres,
  • Others (POC)

Frequently Asked Questions

The hemostasis diagnostics market size was valued at USD 3.98 billion in 2023 and is poised to grow at a CAGR of 9.1% from 2024-2030    

Hoffmann-La Roche Ltd, Sysmex Corporation, Abbott Laboratories, Nihon Kohden Corporation, Siemens, Healthineers, Grifols S.A, Beckman Coulter, Inc.

North America is the fastest-growing region for the hemostasis diagnostics market

1.Executive Summary
2.Global Hemostasis Diagnostics Market Introduction 
2.1.Global Hemostasis Diagnostics Market  - Taxonomy
2.2.Global Hemostasis Diagnostics Market  - Definitions
2.2.1.Product Type
2.2.2.Test Type
2.2.3.Technology
2.2.4.End User
2.2.5.End User
3.Global Hemostasis Diagnostics Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Hemostasis Diagnostics Market Analysis, 2019-2023 and Forecast 2024-2030
4.1.  Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Hemostasis Diagnostics Market  By Product Type, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
5.1. Systems,
5.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Consumables,
5.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Point-of-Care Testing Devices
5.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
6.Global Hemostasis Diagnostics Market  By Test Type, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
6.1. Fibrinogen Test,
6.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Activated Clotting Time,
6.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Platelet Function,
6.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Prothrombin Time,
6.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Heparin & Protamine Dose-Response Test For ACT,
6.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
6.6. Activated Partial Thromboplastin Time,
6.6.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.6.3. Market Opportunity Analysis 
6.7. Anti-Factor Xa,
6.7.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.7.3. Market Opportunity Analysis 
6.8. Other Coagulation Tests
6.8.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
6.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.8.3. Market Opportunity Analysis 
7.Global Hemostasis Diagnostics Market  By Technology, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
7.1. Optical,
7.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Mechanical,
7.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Electrochemical,
7.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Others
7.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
8.Global Hemostasis Diagnostics Market  By End User, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
8.1. Hospitals,
8.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Clinics,
8.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Diagnostic Centres,
8.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Others (POC)
8.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
9.Global Hemostasis Diagnostics Market  By End User, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
9.1. Hospitals,
9.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. Pharmaceutical Companies,
9.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. Food And Beverages Companies,
9.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
9.4. Medical Devices Companies,
9.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.4.3. Market Opportunity Analysis 
9.5. Research Institutes,
9.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.5.3. Market Opportunity Analysis 
9.6. Others
9.6.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
9.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.6.3. Market Opportunity Analysis 
10.Hospitals, Hemostasis Diagnostics Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
10.1. Product Type Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Systems,
10.1.2.Consumables,
10.1.3.Point-of-Care Testing Devices
10.2.  Test Type Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Fibrinogen Test,
10.2.2.Activated Clotting Time,
10.2.3.Platelet Function,
10.2.4.Prothrombin Time,
10.2.5.Heparin & Protamine Dose-Response Test For ACT,
10.2.6.Activated Partial Thromboplastin Time,
10.2.7.Anti-Factor Xa,
10.2.8.Other Coagulation Tests
10.3.  Technology Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Optical,
10.3.2.Mechanical,
10.3.3.Electrochemical,
10.3.4.Others
10.4.  End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Hospitals,
10.4.2.Clinics,
10.4.3.Diagnostic Centres,
10.4.4.Others (POC)
10.5.  Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.5.1.United States of America (USA)
10.5.2.Canada
11.Pharmaceutical Companies, Hemostasis Diagnostics Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
11.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Systems,
11.1.2.Consumables,
11.1.3.Point-of-Care Testing Devices
11.2.  Test Type Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Fibrinogen Test,
11.2.2.Activated Clotting Time,
11.2.3.Platelet Function,
11.2.4.Prothrombin Time,
11.2.5.Heparin & Protamine Dose-Response Test For ACT,
11.2.6.Activated Partial Thromboplastin Time,
11.2.7.Anti-Factor Xa,
11.2.8.Other Coagulation Tests
11.3.  Technology Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Optical,
11.3.2.Mechanical,
11.3.3.Electrochemical,
11.3.4.Others
11.4.  End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.Hospitals,
11.4.2.Clinics,
11.4.3.Diagnostic Centres,
11.4.4.Others (POC)
11.5.  Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.5.1.Germany
11.5.2.France
11.5.3.Italy
11.5.4.United Kingdom (UK)
11.5.5.Spain
11.5.6.Rest of EU
11.5.7.
12.Food And Beverages Companies, Hemostasis Diagnostics Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
12.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Systems,
12.1.2.Consumables,
12.1.3.Point-of-Care Testing Devices
12.2.  Test Type Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Fibrinogen Test,
12.2.2.Activated Clotting Time,
12.2.3.Platelet Function,
12.2.4.Prothrombin Time,
12.2.5.Heparin & Protamine Dose-Response Test For ACT,
12.2.6.Activated Partial Thromboplastin Time,
12.2.7.Anti-Factor Xa,
12.2.8.Other Coagulation Tests
12.3.  Technology Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Optical,
12.3.2.Mechanical,
12.3.3.Electrochemical,
12.3.4.Others
12.4.  End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.Hospitals,
12.4.2.Clinics,
12.4.3.Diagnostic Centres,
12.4.4.Others (POC)
12.5.  Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.5.1.China
12.5.2.India
12.5.3.Australia and New Zealand (ANZ)
12.5.4.Japan
12.5.5.Rest of APAC
13.Medical Devices Companies, Hemostasis Diagnostics Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
13.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Systems,
13.1.2.Consumables,
13.1.3.Point-of-Care Testing Devices
13.2.  Test Type Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Fibrinogen Test,
13.2.2.Activated Clotting Time,
13.2.3.Platelet Function,
13.2.4.Prothrombin Time,
13.2.5.Heparin & Protamine Dose-Response Test For ACT,
13.2.6.Activated Partial Thromboplastin Time,
13.2.7.Anti-Factor Xa,
13.2.8.Other Coagulation Tests
13.3.  Technology Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Optical,
13.3.2.Mechanical,
13.3.3.Electrochemical,
13.3.4.Others
13.4.  End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Hospitals,
13.4.2.Clinics,
13.4.3.Diagnostic Centres,
13.4.4.Others (POC)
13.5.  Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.5.1.GCC Countries
13.5.2.South Africa
13.5.3.Rest of MEA
14.Research Institutes, Hemostasis Diagnostics Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
14.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.1.1.Systems,
14.1.2.Consumables,
14.1.3.Point-of-Care Testing Devices
14.2.  Test Type Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.Fibrinogen Test,
14.2.2.Activated Clotting Time,
14.2.3.Platelet Function,
14.2.4.Prothrombin Time,
14.2.5.Heparin & Protamine Dose-Response Test For ACT,
14.2.6.Activated Partial Thromboplastin Time,
14.2.7.Anti-Factor Xa,
14.2.8.Other Coagulation Tests
14.3.  Technology Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.Optical,
14.3.2.Mechanical,
14.3.3.Electrochemical,
14.3.4.Others
14.4.  End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.Hospitals,
14.4.2.Clinics,
14.4.3.Diagnostic Centres,
14.4.4.Others (POC)
14.5.  Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.5.1.Brazil
14.5.2.Mexico
14.5.3.Rest of LA
15. Competition Landscape
15.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
15.2.1.Hoffmann-La Roche Ltd. (Switzerland)
15.2.2.Sysmex Corporation (Japan)
15.2.3.Abbott Laboratories (U.S.)
15.2.4.Alere Inc. (U.S.)
15.2.5.Nihon Kohden Corporation (Japan)
15.2.6.Siemens Healthineers (Germany)
15.2.7.Grifols S.A (Spain)
15.2.8.Beckman Coulter, Inc. (U.S.)
16. Research Methodology 
17. Appendix and Abbreviations 
  • Hoffmann-La Roche Ltd. (Switzerland)
  • Sysmex Corporation (Japan)
  • Abbott Laboratories (U.S.)
  • Alere Inc. (U.S.)
  • Nihon Kohden Corporation (Japan)
  • Siemens Healthineers (Germany)
  • Grifols S.A (Spain)
  • Beckman Coulter, Inc. (U.S.)

Adjacent Markets